Xplico was established in 2005 with the purpose to develop and market an easy-to-use and standardized tool for valuation of projects and portfolios in the life science industry. Xplico is today the market leader in valuation, supporting more than 100 life science companies in EU, US and Asia on a daily basis.

Currently, Xplico markets three solutions:

Xplico Evaluator is an easy-to-use, flexible valuation tool with integrated risk assessment and powerful analysis features for the life science industry.

Xplico CapTable is an easy-to-use standardized Excel-based tool which is built and tailored to keeping accurate track of multiple ownership and exit scenarios.

Consulting services. We have extensive experience in valuation, forecasting and project/portfolio management and our team of consultants can evaluate your projects and/or company or support you during partnering negotiations.

News from the Xplico world



NLS Days, September 8-9, 2026, Stockholm, Sweden.

Nordic Life Science Days is the largest life science partnering event in the Nordics. NLS Days gathers big pharma executives, investors and CEOs of biotech, pharma and medtech companies and discusses the road ahead for the life science industry.

Please do not hesitate to book a meeting, either during the conference or at a time convenient for you, to discuss how you can benefit from our valuation and consulting services.

(May 2026)


IPLS, September 14-16, 2026, Stockholm, Sweden.

Join business development leaders from across Europe in Stockholm for the 20th anniversary of IPLS, the international partnering event bringing together members from national IPLS groups to spark ideas, deals, and lasting relationships.

Please do not hesitate to book a meeting, either during the conference or at a time convenient for you, to discuss how you can benefit from our valuation and consulting services.

(May 2026)


LSX World Congress, September 23-24, 2026, Boston, USA.

LSX Congress USA is where biotech companies at different stages of growth come to meet the investors and pharma partners who can help shape what comes next. From emerging biotechs seeking capital and visibility to later-stage companies pursuing strategic partnerships and commercial momentum, the event is built around the conversations that matter most.

Please contact us to book a meeting, either during the conference or at a time convenient for you, to discuss how you can benefit from our valuation services.

(May 2026)


Bio-Europe, November 9-11, 2026, Cologne, Germany.

BIO-Europe 2026 is Europe's largest annual life science partnering conference, taking place in Cologne, Germany, from November 9–11. It attracts thousands of executives from global biotech, pharma, and finance to drive strategic licensing, investment, and collaboration across the industry.

Please contact us to book a meeting, either during the conference or at a time convenient for you, to discuss how you can benefit from our valuation services.

(May 2026)